Track the OMNICELL, INC. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 18 August 2026 (Retenue fiscale). Among the most active insiders: Manley Corey J. The full history is openly available.
151
Insider Decl.
n/a
Thresholds
€595,920
2 ops.
Buy Volume
€2m
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate OMNICELL, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$61.47.
38Σ signal
Buys €595,920€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,084 of 29,056 companies
25.6
score / 100
Value
24
Quality
27
FCF yld-3.8%
Earn yld-4.8%
EV/EBITDA·
ROE-40%
Gross mgn42%
Net mgn-11%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
224 shares@ US$43.271.0% of flowCommon StockSEC:0001928727-25-000010:0
25 of 151 declarations
Acerca de OMNICELL, INC.
OMNICELL, INC. es una empresa especializada en soluciones de gestión de medicamentos y atención médica. Ofrece tecnologías innovadoras para mejorar la eficiencia de las farmacias y los centros de atención médica.